Prostate News Archive
03-Feb-2011
Gene test may help spot lethal prostate tumors
prostate tumors with a distinctive four-gene "signature" are far more lethal than others, laying the groundwork for a test to predict which tumors need aggressive treatment, U.S. researchers said on Wednesday. Molecular predictor of metastatic prostate cancer found
prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers now report. The discovery lays the groundwork for the first gene-based test for determining whether a man's prostate cancer is likely to remain dormant within the prostate gland, or spread lethally to other parts of the body. Prostate Cancer Self-Defense: Nine Deadly Myths
Frequent Sex Blocks Prostate Cancer? That's Just One of Many Myths about the Disease Gene test may help spot prostate tumours
Prostate tumours with a distinctive four-gene "signature" are far more lethal than others. Prostate Cancer Genetic Pattern Identified; New Tests, Treatments Underway
prostate cancer is one of the most common forms of cancer and the second leading cause of death in American men. However, today it has been announced that a genetic "signature pattern" has been identified, meaning that advanced tests and treatments to identify and suppress this killer may commence immediately. Metamark Genetics Inc. scientist Ronald DePinho, M.D, and one its founders states ...
Back to Prostate News Archive
